Tag: Ben Bradshaw

The below Parliamentary question was asked by Ben Bradshaw on 2016-05-20.

To ask the Secretary of State for Health, what assessment he has made of whether UK citizens would retain the automatic right to hold the European Health Insurance Card during the period prior to the completion of Article 50 negotiations relating to the Lisbon Treaty in the event of the UK voting to leave the EU.

Alistair Burt

The procedure governing a country’s departure from the European Union is set out in Article 50 of the Treaty on European Union. This provides for a period of two years for the negotiation of exit terms. EU law would continue to apply to the departing Member State until the Article 50 agreement had entered into force, or for two years if no agreement had been reached and no extension to the two year period had been granted. A request for an extension could only be granted with the unanimous agreement of the remaining Member States. The Government’s position is that the United Kingdom will be stronger, safer and better off remaining in a reformed EU.

The below Parliamentary question was asked by Ben Bradshaw on 2016-02-08.

To ask the Secretary of State for Health, what assessment he has made of the potential effect on patient care of reductions in funding of HIV support services from April 2016.

Jane Ellison

Decisions on funding and access to social care support services for people with HIV are made by local authorities. The Care Act 2014 sets out the legal framework for social care in England, and this applies to all adults with support needs including those living with HIV.

Diagnosed early most people with access to HIV treatment can expect a near normal life expectancy. Public Health England monitors the results of individuals receiving NHS HIV treatment. In 2014, 91% of people attending for care were receiving antiretroviral (ARV) treatment of which 95% were virally suppressed and very unlikely to be infectious to others. The United Kingdom is already ahead in meeting two of the three ambitious UNAIDS 90/90/90 global goals of 90% of people with HIV being diagnosed, 90% on ARV treatment and 90% viral suppression for those on ARV treatment by 2020.

The below Parliamentary question was asked by Ben Bradshaw on 2016-03-15.

To ask the Secretary of State for Health, what weighting is being provided to the prevention of genital warts in the decision making process for the contract for the supply of human papilloma virus vaccine.

Jane Ellison

The Department and Public Health England are currently undertaking a procurement exercise to secure vaccine to support the human papillomavirus vaccination programme for girls. As this is a competitive tender, it would not be appropriate to discuss the outcome of the procurement until a contract has been concluded with the successful bidder following the mandatory standstill period.

The procurement will take account of the costs and benefits of all vaccines offered to establish which provides best value for money for the National Health Service. The award criteria are published on the government’s Contracts Finder website:

https://www.contractsfinder.service.gov.uk/Notice/813bc859-8662-4c79-822b-f03cc84b8ceb

The below Parliamentary question was asked by Ben Bradshaw on 2016-05-20.

To ask the Secretary of State for Work and Pensions, whether UK citizens will have automatic right to mutual recognition of pension contributions in EU countries in the event of the UK leaving the EU and prior to the completion of exit negotiations under Article 50 of the Lisbon Treaty.

Stephen Crabb

At the February European Council, the Government negotiated a new settlement, giving the United Kingdom a special status in a reformed European Union. The Government’s position is that the UK will be stronger, safer and better off remaining in a reformed EU. If the result of the referendum is a decision to leave, the Government would have two years under the Article 50 process to seek to negotiate the terms, including those concerning pensions, of the UK’s exit, with the possibility of extending this time frame with the agreement of the other 27 Member States.

The below Parliamentary question was asked by Ben Bradshaw on 2016-02-09.

To ask the Secretary of State for Health, what assessment he has made of the effectiveness of local authorities in carrying out their duties under the new commissioning arrangements to ensure that the needs of people living with HIV in their areas are met.

Jane Ellison

Decisions on funding and access to social care support services for people with HIV are made by local authorities. The Care Act 2014 sets out the legal framework for social care in England, and this applies to all adults with support needs including those living with HIV.

Diagnosed early most people with access to HIV treatment can expect a near normal life expectancy. Public Health England monitors the results of individuals receiving NHS HIV treatment. In 2014, 91% of people attending for care were receiving antiretroviral (ARV) treatment of which 95% were virally suppressed and very unlikely to be infectious to others. The United Kingdom is already ahead in meeting two of the three ambitious UNAIDS 90/90/90 global goals of 90% of people with HIV being diagnosed, 90% on ARV treatment and 90% viral suppression for those on ARV treatment by 2020.

The below Parliamentary question was asked by Ben Bradshaw on 2016-03-15.

To ask the Secretary of State for Health, what assessment his Department has made on the likely incidence of recurrent respiratory papillomatosis in the event that the (a) quadrivalent vaccine is maintained for UK HPV vaccination programme for girls and (b) bivalent vaccine is introduced for the UK HPV vaccination programme for girls.

Jane Ellison

The Department has not estimated the impact on the incidence of recurrent respiratory papillomatosis if the bivalent vaccine replaces the quadrivalent vaccine in the human papillomavirus (HPV) vaccination programme for girls.

Warwick University is carrying out some limited analysis, in the context of its modelling work on the impact and cost effectiveness of extending HPV vaccination to boys, but the results are academically and commercially confidential, and subject to review by the Joint Committee on Vaccination and Immunisation, the independent expert body that advises Ministers on immunisation matters.

Estimates of the potential impact of the HPV vaccination programme on cancer and warts, including the incidence of recurrent respiratory papillomatosis, have been previously published by Public Health England in the British Medical Journal in 2011:

http://www.bmj.com/content/343/bmj.d5775

The below Parliamentary question was asked by Ben Bradshaw on 2016-09-13.

To ask the Secretary of State for Business, Energy and Industrial Strategy, whether he has made an assessment of the implications for his Department’s policies of the report, Seeing through the gloom, UK solar seeks stability after subsidy cut, published in July 2016.

Jesse Norman

Solar in the UK has been a success story with 11 gigawatts deployed, over 99% of which has been delivered under Conservative-led Governments since May 2010.

Changes to the Feed-in Tariff scheme were introduced in 2016 to manage costs and ensure value for money. We note the efforts that the solar industry is making to adapt to the revised scheme. We have received the report ‘Seeing through the gloom’ and noted its findings.

The below Parliamentary question was asked by Ben Bradshaw on 2016-02-09.

To ask the Secretary of State for Health, how many HIV support services are planned to be affected by changes in funding from April 2016; and how many people used each of those services in the last 12 months.

Jane Ellison

Decisions on funding and access to social care support services for people with HIV are made by local authorities. The Care Act 2014 sets out the legal framework for social care in England, and this applies to all adults with support needs including those living with HIV.

The below Parliamentary question was asked by Ben Bradshaw on 2016-03-15.

To ask the Secretary of State for Health, what assessment he has made on the emotional and psychological effect of acquiring genital warts on an individual.

Jane Ellison

The Department has not made a specific assessment of the emotional and psychological effects of acquiring genital warts.

However, it has made use of broader cost-effectiveness analysis, which includes both the physical and mental effects of genital warts, when assessing the human papillomavirus vaccination programme.

The below Parliamentary question was asked by Ben Bradshaw on 2016-10-20.

To ask the Secretary of State for Communities and Local Government, what assessment he has made of the effect on the solar power industry of the proposed 2017 business rate rise for organisations investing in rooftop solar power for their own consumption.

Mr Marcus Jones

Business rates are based on valuations from the Valuation Office Agency and we do not intervene in their independent assessments. We have proposed a £3.4 billion transitional relief scheme to ensure that no ratepayer is unfairly penalised by the 2017 revaluation.